HIGHLIGHTS
- who: Pei Yang from the Peking University People`s Hospital, China have published the paper: Effects of sacubitril/valsartan on cardiac reverse remodeling and cardiac resynchronization in patients with acute myocardial infarction, in the Journal: (JOURNAL) of 13/01/2023
- what: The main reason for this is coronary atherosclerosis, after which multiple triggers lead to the rupture of unstable plaques and thrombosis. The design of this trial has been approved by the Ethics Committee of the Second Affiliated Hospital of Air Force Military Medical University (No 20190906) and registered in the China Clinical Trials Registration . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.